Thermo Fisher Scientific Expands its Global Biologics and Steriles Manufacturing Capabilities in China
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Recent searches
Clear History
Suggestions
All Results
Search
US | EN
With the rapid expansion of the cell and gene therapy market, innovators will require reliable supply chain solutions to enable the safe and efficient transportation of products to patients in need. The following article highlights several industry challenges and considerations as clients prepare for commercialization of advanced therapy products, as well as potential solutions to address some of the most complex issues such as ensuring product integrity, maintaining chain of custody, adhering to tight timelines, and more.